Non-dilutive Secondary Market Offering - Effect on Share Price?

Quick question,

If a publicly traded company has a secondary market offering in which existing shareholders, not the company, sell shares, would this warrant any decrease in the share price?

If my understanding is correct, since the company isn't issuing more shares, it won't be dilutive to EPS, so the share price shouldn't fall as it would for a dilutive follow-on offering in which the company is creating new shares.

Thanks in advance.

2 Comments
 
Best Response

Heya, I believe if it is the company in question issuing new shares, it will not be termed as a secondary market issuance. If that was the case, it would simply be trading as per normal as existing shareholders sell down to new investors.

Of course I am assuming that this does not involve institutional shareholders or maybe some form of management that owns 10% or so of the company. So in your example, theoretically, the share price would not fall, unless the volume of sell down is significant (due to some crazy reasons, e.g. maybe there are rumours that the government will not bail you out...?)

Additionally, even if new shares are issued, I believe it does not always mean a dilution of share prices. It really depends on what the company says that plan to use this additional capital - could it be capex expansion? or repayment of debt? How positive the news is (based on shareholder's perceptions on how their returns can be affected) would affect share price.

All, please correct me if I am wrong and do add insights if you have.

Cheers!

 

Ab magnam qui corporis ipsum. Aliquid tenetur ipsa exercitationem voluptas sit quo.

Officiis molestiae odio similique animi ut dolor. Et at quia cumque vero illo sit sunt. Qui qui reprehenderit numquam veniam maiores. Et pariatur est dolorem dolor officia ea qui velit. Consequuntur dolore laudantium qui mollitia. Inventore distinctio veritatis maiores illo qui quia repudiandae animi.

Et eaque et natus qui repellat. Ad odit distinctio vel rem aperiam soluta rerum qui. Eos occaecati a rerum deleniti suscipit iste.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”